Measuring outcomes

Metabolic-associated fatty liver disease clinical audit

Clinical audit | Hours: 6 | EA: 1 | MO: 4 | RP: 1 | GPs only

In this clinical audit, you will conduct an assessment of patients who are at risk of metabolic associated fatty liver disease (MAFLD), calculate their risk of liver fibrosis using validated tools and decide on further management.

Read more about Metabolic-associated fatty liver disease clinical audit

Practical use of long-acting injectable buprenorphine for the treatment of opioid dependence

Hours: 2 | EA: 1 | MO: 1 | RP: 0

Module 2 of 2: This two-part activity provides education on the various long-acting buprenorphine (LAIB) formulations available in Australia, followed by a practical exercise where the learner goes through the steps of assessing whether a patient is suitable for LAIB treatment, and discusses with them how treatment may help them achieve their goals.